Mary Madison, RN, RAC-CT, CDP
Clinical Consultant – Briggs Healthcare
The Centers for Disease Control and Prevention (CDC) is preparing for co-circulating influenza virus, SARS-CoV-2, and respiratory syncytial virus (RSV) this fall and winter. Vaccines can provide life-saving protection against all three viral respiratory diseases. CDC recommends these vaccines for older adults, who are at a higher risk of severe illness from these diseases. Clinicians play a vital role in ensuring that older adults protect themselves by encouraging them to stay up to date on influenza, COVID-19, and RSV vaccinations.
Date: Tuesday, September 19, 2023
Time: 2:00 PM – 3:00 PM ET
Webinar Link:
https://www.zoomgov.com/j/1606020154?pwd=RTV5Z1Y5dlR6alVXbFplb0JzR0dDQT09
Webinar ID: 160 602 0154
Passcode: 493303
Telephone:
+1 669 254 5252 or 1 646 828 7666 US
One-tap mobile:
+16692545252,,1606020154#,,,,*493303# or +16468287666,,1606020154#,,,,*493303#
During this COCA Call, CDC presenters will provide updates about the latest recommendations and clinical considerations for administering influenza, COVID-19, and RSV vaccines to adults 60 years and older and discuss resources and communication strategies that may help facilitate older adult vaccination.
If you are unable to attend the live COCA Call, the recording will be available for viewing on the COCA Call webpage a few hours after the live event ends.
The slide set will be available on the day of the call on the COCA Call webpage under Call Materials.
Free Continuing Education (CE) will be offered for this COCA Call.
Registration is not required.
To receive continuing education (CE) for WC4520-091923 – Clinician Outreach and Communication Activity (COCA)Calls/Webinars – Preparing for the Upcoming Respiratory Virus Season: Recommendations for Influenza, COVID-19, and RSV Vaccines for Older Adults, Tuesday, September 19, 2023, please visit TCEO and follow these 9 Simple Steps by Monday, October 23, 2023.
To receive continuing education (CE) for WD4520-091923 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Preparing for the Upcoming Respiratory Virus Season: Recommendations for Influenza, COVID-19, and RSV Vaccines for Older Adults, Tuesday, September 19, 2023, (Web on Demand), please visit TCEO and follow these 9 Simple Steps between Tuesday, October 24, 2023, and Friday, October 24, 2025.
In support of improving patient care, the Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: The Centers for Disease Control and Prevention designates this activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA CME: The Centers for Disease Control and Prevention has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid until 12/13/2023. PAs should only claim credit commensurate with the extent of their participation.
CNE: The Centers for Disease Control and Prevention designates this activity for 1 nursing contact hours.
CPE: The Centers for Disease Control and Prevention designated this (Knowledge-based) event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is JA4008229-0000-23-077-L04-P and enduring JA4008229-0000-23-078-H04-P.
Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 1. Continuing Competency credits available are 1. CDC provider number 98614.
AAVSB/RACE: This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.
For Certified Public Health Professionals (CPH): The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credits for this program.
DISCLOSURE: In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.
CDC, our planners, and presenters wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Dr. Lisa Grohskopf’s discussion of FDA-approved package inserts for egg-based influenza vaccines that indicate that their use is contraindicated for persons who have had a severe allergic reaction to any vaccine component which includes egg for egg-based vaccine. However, the ACIP and CDC recommend that persons with egg allergy of any severity should receive influenza vaccine, and that they may receive any influenza vaccine that is otherwise appropriate for age and health status (egg based or non-egg based). CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
BriggsNetNews 